Redpoint Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $147K | Hold |
18,252
| – | – | 0.02% | 571 |
|
|
2022
Q2 | $137K | Hold |
18,252
| – | – | 0.02% | 602 |
|
|
2022
Q1 | $171K | Hold |
18,252
| – | – | 0.02% | 617 |
|
|
2021
Q4 | $146K | Hold |
18,252
| – | – | 0.01% | 641 |
|
|
2021
Q3 | $178K | Hold |
18,252
| – | – | 0.02% | 641 |
|
|
2021
Q2 | $181K | Hold |
18,252
| – | – | 0.01% | 662 |
|
|
2021
Q1 | $211K | Buy |
+18,252
| New | +$211K | 0.02% | 638 |
|
|
2020
Q4 | – | Sell |
-19,695
| Closed | -$177K | – | 630 |
|
|
2020
Q3 | $177K | Sell |
19,695
-2,244
| -10% | -$20.2K | 0.02% | 561 |
|
|
2020
Q2 | $271K | Hold |
21,939
| – | – | 0.02% | 509 |
|
|
2020
Q1 | $197K | Hold |
21,939
| – | – | 0.01% | 527 |
|
|
2019
Q4 | $215K | Hold |
21,939
| – | – | 0.01% | 584 |
|
|
2019
Q3 | $151K | Sell |
21,939
-45,357
| -67% | -$312K | 0.01% | 585 |
|
|
2019
Q2 | $621K | Hold |
67,296
| – | – | 0.03% | 425 |
|
|
2019
Q1 | $1.06M | Buy |
67,296
+6,338
| +10% | +$99.4K | 0.05% | 376 |
|
|
2018
Q4 | $940K | Hold |
60,958
| – | – | 0.05% | 367 |
|
|
2018
Q3 | $1.31M | Hold |
60,958
| – | – | 0.07% | 334 |
|
|
2018
Q2 | $1.48M | Hold |
60,958
| – | – | 0.08% | 304 |
|
|
2018
Q1 | $1.04M | Hold |
60,958
| – | – | 0.06% | 352 |
|
|
2017
Q4 | $1.16M | Buy |
+60,958
| New | +$1.16M | 0.06% | 345 |
|